Liver Enzymes in Athletes: When Elevated ALT and AST Are Not a Liver Problem
Table of Contents
Introduction: Why Liver Enzymes in Athletes Require a Different Framework
In my clinical work, I frequently encounter elevated liver enzyme levels such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in athletic patients undergoing blood testing. This is a well-recognised incidental finding in this population and understandably often causes concern. However, in many cases, the elevation does not reflect a serious liver condition, but rather a physiological response to physical training. For the clinician, this creates a recurrent diagnostic challenge: distinguishing exercise-induced transaminase elevation from a genuinely pathological hepatic process. The two can be numerically indistinguishable on a standard liver panel — yet their clinical implications are fundamentally different.
This can be explained by the fact that, in athletes, ALT and AST levels may rise for physiological reasons independent of liver function. A hard-training weightlifter presenting with AST four times the upper limit of normal and ALT twice the upper limit may be entirely healthy, with the elevation representing the biochemical consequences of intense skeletal muscle activity. In contrast, the same values in a sedentary patient with fatigue and right upper quadrant discomfort would warrant prompt hepatological evaluation.
In this article, I outline a practical, clinician-oriented framework for interpreting liver enzymes in athletes. I focus on the biochemical basis of exercise-induced transaminase elevation, the pattern-recognition tools I use to distinguish this from hepatic pathology, and the clinical approach I take when deciding whether further investigation is needed or whether it is reasonable to wait and reassess. For a broader overview of laboratory testing in this population, see which blood tests athletes actually need.
Why Standard Reference Ranges Fail When Interpreting Liver Enzymes in Athletes
In clinical practice, ALT is one of the most commonly measured liver enzymes, particularly in settings such as Finland where it is included in most standard laboratory panels. In routine screening, evaluation often begins with ALT, and if it is found to be elevated, further liver-related tests are typically added. Alternatively, if there is a clinical suspicion of abdominal or hepatobiliary pathology from the outset, a broader panel may be ordered immediately. Abnormal liver enzyme values are therefore often detected incidentally during occupational health screenings or periodic evaluations in athletes, as well as in the workup of patients presenting with abdominal symptoms.
ALT and AST are intracellular enzymes involved in amino acid metabolism. They are located within cells and enter the bloodstream when cell membranes are disrupted or become more permeable. The clinical assumption underlying standard liver panels is that elevated serum levels reflect hepatocyte injury — and in the general population, this assumption is often reasonable. However, both enzymes are also expressed in tissues outside the liver, particularly in skeletal muscle, which is an important consideration when interpreting results in physically active individuals.
AST is found in high concentrations not only in hepatocytes but also in skeletal muscle, cardiac muscle, kidneys, red blood cells, and the brain. ALT, while more hepatocyte-selective, is also present in skeletal muscle. A key consideration, often overlooked in clinical practice, is that absolute skeletal muscle mass in humans vastly exceeds liver mass — estimated at 21 kg in women and 33 kg in men on average. Even modest changes in enzyme release per gram of muscle tissue may therefore be significant when amplified across tens of kilograms of tissue [1].
Exercise, by design, induces muscle damage. Eccentric loading, high-intensity resistance work, and prolonged endurance effort all disrupt muscle fibre integrity as part of normal adaptive physiology. This disruption releases intracellular contents — including AST and ALT — into the circulation. The elevation that results is not a signal of pathology. It is the biochemical signature of training. This is the same physiological mechanism behind the markedly elevated creatine kinase in athletes seen after hard training sessions.
In these situations, when an athlete is found to have elevated AST or ALT levels, the next step is typically to take a thorough history. In particular, I ask about the volume and intensity of training, as well as when the patient last exercised. If the history does not clearly explain the finding, the next step is to review the rest of the liver panel, as discussed later in this article. Certain liver-related markers are not present in skeletal muscle and can therefore help differentiate between muscle-related and hepatic causes. If uncertainty persists, imaging such as liver ultrasound may be considered to evaluate for underlying hepatic pathology.
The Evidence: How High Do Liver Enzymes in Athletes Rise, and How Long Do They Stay Elevated?
The landmark experimental demonstration of exercise-induced transaminase elevation was provided by Pettersson and colleagues, who studied 15 healthy men unaccustomed to weightlifting. After a single one-hour weightlifting session, AST, ALT, lactate dehydrogenase (LD), creatine kinase (CK), and myoglobin all increased significantly and remained elevated for at least seven days. Of particular clinical importance: bilirubin, gamma-glutamyl transferase (GGT), and alkaline phosphatase (ALP) remained within normal ranges throughout [2]. This dissociation — transaminases elevated while GGT, bilirubin, and ALP remain normal — is consistent with muscle-origin enzyme release and will be discussed further in the diagnostic section below.
In endurance athletes, the picture is dose-dependent on exercise volume. A prospective observational study comparing athletes after marathons, 100 km ultramarathons, and 308 km ultramarathons found that CK, LD, AST, and ALT were all significantly elevated immediately after completion of each race, with values rising progressively with distance [3]. The broader post-race blood picture — including how these liver enzymes in athletes behave alongside other markers after a marathon — is covered in detail in the article on post-marathon blood work.
The duration of post-exercise elevation is clinically relevant when interpreting blood results. After intense resistance exercise, transaminase elevations can persist for at least seven days [2]. In highly trained, lifelong athletes engaged in continuous high-volume training, a degree of chronic background elevation may be effectively persistent. A case report in the Journal of Family Medicine and Primary Care described a lifelong-trained male athlete whose LFT values were elevated at 1.4–2.3 times the normal limit, with all values normalising following seven days of rest. The authors explicitly raised the question of whether exercise-associated transaminase elevation in active individuals represents a knowledge gap in primary care [4].
From a clinical perspective, I tend to focus more on the degree of elevation rather than the mere presence of elevated values. Mild increases in ALT and AST are, in my experience, relatively non-specific findings. When the levels are only slightly elevated, I usually take a measured approach rather than initiating immediate extensive investigations.
There are many possible causes of elevated liver enzymes. While exercise is one of them, more common causes include conditions such as non-alcoholic fatty liver disease and alcohol use. Even in athletic populations, these should not be overlooked. In practice, when I encounter mild elevations, my first step is to take a thorough history and arrange follow-up testing rather than proceed directly to extensive diagnostics.
If the abnormalities persist on repeat measurements, I then move toward broader evaluation. It is also important to recognise that mild, transient elevations can occur in a range of conditions, including viral illnesses affecting the liver. For this reason, when elevations are modest and the clinical picture is otherwise unremarkable, I generally consider it reasonable to monitor the situation initially and reassess before escalating the workup.
The Diagnostic Challenge: Distinguishing Muscle from Liver as the Source of Elevated Liver Enzymes in Athletes
The fundamental difficulty is that the difference between a muscle and a liver source of AST and ALT is quantitative rather than qualitative [1]. Both tissues release the same enzymes, and the serum measurement cannot itself identify tissue origin. Pattern recognition across the full biochemical panel is therefore essential.
From a broader clinical perspective, this is not unique to hepatology. Historically, AST and related enzymes were also used as markers in cardiac disease, particularly in the context of myocardial ischemia. However, these markers lacked specificity, as they are released from multiple tissues. With the development of cardiac troponins, which are far more specific to myocardial injury, the role of AST in cardiac diagnostics has largely diminished. I find this parallel helpful in understanding the limitations of AST and ALT — while they signal cellular injury, they do not, on their own, reliably identify its source.
The Role of GGT
GGT is not found in skeletal muscle. Its synthesis and release are associated with biliary epithelium and hepatocytes, not myocytes. When evaluating liver enzymes in athletes, a normal GGT (often reported simply as “GT” in Finland) is consistent with muscle-origin enzyme release, while an elevated GGT increases the probability of genuine hepatic involvement [1].
This was demonstrated practically by Dickerman and colleagues in a case-control study of elite bodybuilders using and not using anabolic steroids, compared with patients with confirmed viral hepatitis. In both groups of bodybuilders, CK, AST, and ALT were elevated while GGT remained within normal limits. In contrast, hepatitis patients showed elevations of all three enzymes: AST, ALT, and GGT. Patients with hepatitis were the only group in which aminotransferases correlated with GGT. The authors concluded that prior reports of anabolic steroid-induced hepatotoxicity based on aminotransferase elevations alone may have been overstated, because GGT levels did not indicate hepatic dysfunction in any exercising subject — including steroid users [5].
The clinical implication is clear: ordering GGT alongside AST and ALT is a low-cost, high-yield step in the evaluation of any athlete with elevated transaminases. A normal GGT is more consistent with a muscle source; an elevated GGT shifts attention toward the liver.
GGT (often reported simply as “GT”) is known to be particularly sensitive to alcohol intake — something many of us remember from medical school with the tongue-in-cheek phrase “gin and tonic.” In practice, when GGT is elevated alongside AST and ALT, it increases the likelihood of a hepatic source. Conversely, a normal GGT lowers the probability of underlying liver pathology, although it does not exclude it entirely.
Bilirubin and ALP
Bilirubin and Alkaline phosphatase(ALP) are not released by skeletal muscle. In the Pettersson weightlifting study, both markers remained within normal limits despite marked elevations in AST and ALT [2]. Isolated elevation of aminotransferases with normal bilirubin, normal ALP, and normal GGT is a pattern consistent with extrahepatic — most likely skeletal muscle — origin. It is worth noting that bilirubin elevation has been observed after prolonged endurance events such as 100 km and 308 km ultramarathons [3]; the specific behaviour of bilirubin in athletes is is exercise-dose-dependent and likely multifactorial, involving intravascular hemolysis, increased hemoglobin turnover, and transient impairment of hepatic bilirubin clearance rather than primary hepatocellular injury
However, bilirubin rarely excludes liver disease on its own. It is more appropriately interpreted as a marker of impaired bile flow, often associated with cholestasis — whether intrahepatic or extrahepatic — such as obstruction or disruption of normal biliary transport. In practice, when bilirubin is elevated, the initial considerations are often biliary obstruction or hepatitis. In some cases, I may also see patients presenting with jaundice. ALP is often more informative in this context, particularly when a cholestatic pattern is suspected, although elevations can also originate from non-hepatic sources such as bone. In my experience, gastroenterologists may take particular interest when ALP is elevated, given its relevance in hepatobiliary disease.
Creatine Kinase as the Muscle Damage Marker
CK is a key marker of muscle injury. In the context of elevated liver enzymes in athletes, a concurrent elevation in CK provides direct evidence that muscle breakdown is occurring and should inform the interpretation of the transaminase finding. This principle extends to pathological muscle damage: in a retrospective review of 215 rhabdomyolysis cases (CPK ≥ 1,000 U/L), abnormal AST was found in 93.1% of patients (95% CI, 88.7%–95.8%), while abnormal ALT was found in 75.0% (95% CI, 68.7%–80.2%). Critically, AST concentrations fell in parallel with CK during the first six days of hospitalisation, consistent with a muscle rather than hepatic source [6].
In a study of 16 patients with significant muscle necrosis from extreme exercise, polymyositis, or seizures — with no evidence of underlying liver disease — both AST and ALT were elevated. In acute presentations, the AST/ALT ratio was greater than 3, and approached 1 after several days as AST cleared more quickly than ALT [7]. This pattern reflects the differential half-lives of the two enzymes — ALT has a serum half-life of approximately 47 hours compared to approximately 17 hours for AST [8] — and does not, in isolation, point to a hepatic aetiology.
The practical consequence is that CK should be added to the investigation whenever elevated liver enzymes in athletes are identified. Ordering a liver panel without CK in this population risks initiating a hepatological workup that is unnecessary, costly, and potentially harmful if it leads to liver biopsy. The clinical significance of creatine kinase in athletes is covered in a separate article.
When ALT and AST are elevated, creatine kinase (CK) is a useful addition to the differential diagnosis. If CK is also elevated, it may point toward muscle injury, shifting the clinical suspicion away from primary hepatic pathology and toward a muscle-derived source of enzyme release. From a clinical standpoint, this is why I aim to consider and, where appropriate, rule out rhabdomyolysis early in the evaluation — particularly when transaminase elevations are marked or accompanied by significant increases in CK.
References
- https://pubmed.ncbi.nlm.nih.gov/32205993/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2291230/
- https://doi.org/10.1097/MD.0000000000003657
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10071916/
- https://pubmed.ncbi.nlm.nih.gov/10336050/
- https://pubmed.ncbi.nlm.nih.gov/20407858/
- https://pubmed.ncbi.nlm.nih.gov/15660433/
- https://pubmed.ncbi.nlm.nih.gov/18366115/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6019459/
- https://pubmed.ncbi.nlm.nih.gov/29431403/
